PTEN is a dual function phosphatase with tumor suppressor function compromised in a wide spectrum of cancers. Because tissue polarity and architecture are crucial modulators of normal and malignant behavior, we postulated that PTEN may play a role in maintenance of tissue integrity. We used two non-malignant human mammary epithelial cell lines (HMECs) that form polarized, growth-arrested structures (acini) when cultured in 3-dimensional laminin-rich extracellular matrix gels (3D lrECM). As acini begin to form, PTEN accumulates in both the cytoplasm, and at cell-cell contacts where it colocalizes with E-cadherin/β-catenin complex. Reduction of PTEN levels by shRNA in lrECM prevents formation of organized breast acini and disrupts growth arrest.
INTRODUCTION
The dual function phosphatase, PTEN (MMAC/TEP-1), is one of the most common targets of mutations in human cancers (1-4). Yet, in the context of breast cancer, PTEN mutations are not common, affecting less than 5% of patients. Nevertheless 30-50% of breast cancer patients have reduced PTEN expression, which in turn, is associated with poor clinical outcome (5, 6) . Approximately 50% of patients with breast cancer have a mutation in or loss of at least one copy of the PTEN gene, which results in the activation of the phosphoinositide 3-kinase (PI3K) signaling (7, 8) . The severity of PTEN mutations strongly correlates with the tumor stage and grade. For example, complete loss of PTEN is more frequent in metastatic cancer than in primary tumors. The loss of one copy of PTEN increases the risk that a tumor will develop; and the level of expression of PTEN dramatically affects the initiation and progression of tumors in mice models (9) . Low expression of PTEN correlates also with unresponsiveness to breast cancer therapies such as trastuzumab (Herceptin) (10) , Tamoxifen (11) and Gefitinib (12) . Thus an understanding of how PTEN levels and its subcellular localization are regulated is important for understanding the mechanism by which PTEN may be involved in protecting breast cells from proceeding to malignancy. PTEN acts as a tumor suppressor, in part, by regulating or attenuating the activity of the oncogene phosphoinositide 3-kinase (PI3K). There is some evidence that it does so through catalyzing the degradation of a critical second messenger, phosphotidylinositol-(3,4,5)-triphosphate (PIP3), generated by PI3K (7) . PTEN activity negatively influences multiple PI3K downstream targets, most notably PKB/Akt (13) (14) (15) and exogenous addition of PTEN suppresses the growth of tumor cells (16) (17) (18) by upregulation of p27kip1 and downregulation of cyclin D1 in an Akt-dependent manner (19, 20) . PTEN functions also in regulating dynamic cell surface interactions that involve integrins, focal adhesion kinase (FAK), cell migration, and the cytoskeleton (21) (22) (23) (24) . Moreover, it has been demonstrated that PTEN interacts with cell adhesion molecules such as β-catenin and E-cadherin through MAGI-2 protein to inhibit migration and proliferation (25) (26) (27) (28) . In all these studies, however, PTEN's involvement has been studied on two dimensional (2D) tissue cultures. We hypothesized that the multiple consequences of loss of PTEN function observed in breast cancer could be related to a crucial but epigenetic role of PTEN in tissue-specific integration of form and function.
Recently, several reports have indicated that PTEN shuttles between the nuclear and cytoplasmic compartments. Nuclear PTEN is primarily found in normal cells and directly correlates with cell differentiation (29) . A short sequence in the N-terminal region of PTEN has been identified to localize PTEN in the cytoplasm (30) . Neither the cause(s) nor the consequences of these differences in PTEN sub-cellular localization have been studied in a physiologically relevant model.
The phosphorylation state of PTEN contributes to the regulation of PTEN sub-cellular localization and function. PTEN phosphorylation at serine 380 (ser380) and threonines 382/383 (thr382/383) within its C-terminal tail strongly influences PTEN protein stability and its localization to the cell membrane. Several kinases, including casein kinase-2, LKB1, RhoA-associated kinase, the microtubule associated kinase MAT205 and GSK 3β have been reported to phosphorylate PTEN (29) .
One of the earliest manifestations of breast cancer is the loss of cellular organization within a tissue. This loss of function can be mimicked in 3D culture systems where its causes can be readily studied. In 3D lrECM, non-malignant HMEC form polarized, selforganizing structures that closely resemble structures observed in the mammary gland in vivo, whereas malignant cells form structures that remain disorganized (31) . We have shown that signaling pathways respond to microenvironmental cues analogous to those that occur in mammary acini in vivo (32) . Recently we demonstrated additional utility of 3D lrECM cultures of non-malignant HMEC for identification of molecular signatures predictive of clinical outcome in breast cancer (33) . The expression patterns of genes significantly down modulated during acinar morphogenesis in 3D cultures could be used to distinguish groups of patients with poor-versus good-prognosis. Thus, 3D lrECM cultures of HMEC offer an opportunity to study the regulation of endogenous PTEN in a manipulatable and physiologically relevant context.
Here, we used the 3D lrECM cultures of non-malignant HMECs to investigate possible new roles for PTEN and how its level is regulated by microenvironment cues. We found that PTEN is indeed involved in acini formation and growth arrest. We also show that its level and localization is modulated by E-cadherin.
MATERIALS AND METHODS

Cell Culture.
Immortalized non-malignant HMT-3522 S1 (S1) HMEC (34) were cultured in H14 medium (DMEM/F12 containing 250 ng/ml insulin, 10 µg/ml transferrin, 2.6 ng/ml sodium selenite, 10-10 M estradiol, 1.4 x 10-6 M hydrocortisone, 10 ng/ml EGF and 5 µg The full microarray results were published in a previous study (33) and data can be retrieved at the public database links GEOSeries GSE8096 and ArrayExpress E-MEXP-1006. In short, cell samples were harvested in duplicate at 3, 5, and 7 days post-seeding in lrECM. Purified total cellular RNA was biotin-labeled and hybridized to human oligonucleotide microarrays (Affymetrix HG-U133A), as previously described (33) .
Experiments with Affymetrix-present P-call rates of >30% were included in the analysis.
Signal values from each of the 22,283 probe sets were calculated by means of robust multi-array analysis (RMA) (37) and genes were normalized to the mean of the 3-day time point for each cell type. Transcripts exhibiting greater than 2-fold differences in 2 independent microarray experiments were analyzed by 1-way ANOVA as a function of time in 3D cultures. Genes that were significantly differential (p<0.05) were selected.
From these, we identified genes that were modulated early in the time-course (by our definition, on day 5) in both cell types. Three probe sets on Affymetrix HG-U133A
GeneChips uniquely match PTEN: including 204054_at, 204053_x_at, and 211711_s_at
(GeneCards/GeneTide data). Results represent the mean +/-the standard error of the three probes.
Indirect immunofluorescence and image acquisition.
Acinar structures were fixed on 4 well chamber glass slides in methanol-acetone (1:1) at -20°C for 10 minutes and air-dried. A primary block was performed in IF Buffer (130 mM NaCl, 7 mM Na2HPO4, 3.5 mM NaH2PO4, 7.7 mM NaN3, 0.1% bovine serum albumin, 
Flow cytometry.
Acini were dispersed into single cell suspensions by treatment with 0.25% trypsin at 37°C for exactly 10 minutes. The dispersed cells were washed three times in PBS and fixed in 40% ethanol at 4°C overnight. They were then incubated with 500 µg /ml RNase A in PBS at 37°C for 30 minutes and stained at room temperature for 30 minutes with a 69 µM propidium iodide solution prepared in PBS. The DNA content was determined by flow cytometry using a FACScan (Becton Dickinson, Franklin Lakes, NJ), and the data were analyzed with Cell Quest software (Becton Dickinson, Franklin Lakes, NJ).
Immunoblot and immunoprecipitation.
Cell lysates (20-100 μg protein) were separated by SDS-PAGE gel electrophoresis and transferred to PVDF membranes (Millipore, Billerica, MA). After blocking in 10% nonfat dry milk for 90 minutes at room temperature, the membranes were incubated with primary antibodies at 1:500 to 1:1000 dilution in 2% nonfat dry milk for 2 hours at room temperature or overnight at 4°C. The blots were then incubated with HRP-conjugated We showed previously that both PI3K and PIP3 were polarized to the basal surface of mammary acini (39) . To determine whether PTEN-ser380 is co-localized to this surface in growth-arrested acini as well, we performed indirect immunofluorescence and confocal microscopy. We observed that PTEN-ser380 indeed was enriched at cell-cell contacts where E-cadherin, β-catenin and MAGI-2 was localized ( Figure 2A ). This suggested that PTEN may be part of the E-cadherin/β-catenin complex at cell-cell junctions. To explore this possibility, we performed co-immunoprecipitation studies using a polyclonal antibody against β-catenin. We observed increased ratio of PTEN protein complexed with β-catenin/E-cadherin in cells incubated in lrECM compared to conventional adherent (2D) conditions (PTEN/β-catenin ratio: 0.4 in 3D vs 0.1 in 2D) ( Figure 2B ).
Reduced PTEN levels during mammary acini formation abrogate lrECM-induced growth arrest.
To critically test the contribution of increased PTEN expression to the lrECM-mediated growth arrest and self-organization of non-malignant HMEC in 3D cultures, we expressed PTEN shRNA stably in 184 HMEC using retroviruses. Immunoblotting of total cell extracts confirmed that PTEN protein levels were inhibited by almost 50% in cells expressing PTEN shRNA compared to cells expressing a control scrambled shRNA (40) 3. E-cadherin function regulates acinus polarity, cellular proliferation, and PTEN levels.
Given the increased association among PTEN, β-catenin, and E-cadherin during HMEC acinar morphogenesis, we hypothesized that E-cadherin may directly modulate the levels and subcellular localization of PTEN. E-cadherin plays a key role in the structural organization of cell-cell adhesion and serves as a widely recognized suppressor of invasion and proliferation of epithelial cancers. In addition, its functional elimination represents a key step in the acquisition of the invasive phenotype for many tumors, including breast cancers. Consistent with previous reports (36, 41, 42) , we observed that blocking E-cadherin-dependent cell-cell contact using neutralizing antibodies, disrupted the cell cycle arrest and polarity of HMEC cultured in 3D lrECM. Cultures treated with E-cadherin blocking antibodies lost basal-restricted staining for α-6 integrin ( Figure 4A) and had strong nuclear staining for Ki67 ( Figure 4B) . Moreover, the number of cells/acinus cross-section was increased in cultures treated with the E-cadherin blocking antibody compared to those treated with a control IgG antibody ( Figure 4C ). Immunoblot analysis showed that the levels of cytoplasmic PTEN-ser380 in E-cadherin blocking antibody-treated cultures were reduced by approximately 30% compared to those in control IgG-treated cultures ( Figure 5A ). Total PTEN protein levels were also reduced as a result of neutralizing E-cadherin function ( Figure 5B ). Conversely, we observed robust induction of cyclin E in cytoplasmic and nuclear extracts of HMEC in the same cultures.
In both S1 (p53 negative) and 184 (p53 wild type) HMEC cultures treated with Ecadherin blocking antibody, we observed a reduction of PTEN levels at cell-cell interactions ( Figure 5C ). These results indicate that blocking E-cadherin function in HMEC in 3D lrECM has profound consequences for PTEN activation, acinar polarity and loss of growth control.
Restoration of E-cadherin function in the malignant breast cancer cell line SKBR3 restores PTEN expression.
Having shown that E-cadherin function is important for maintaining PTEN expression levels, we examined whether re-expression of E-cadherin could restore PTEN-ser380
protein expression patterns in a breast cancer cell line, Skbr-3, that lacks E-cadherin.
Expression of vector control or E-cadherin gene in Skbr-3 cells was confirmed by immunofluorescent analysis (Figure 6 and Suppl Figure 1 ). Figure 6 shows that in Skbr-3
cells expressing E-cadherin, PTEN-ser380 immunofluorescence was prominent at sites of cell-cell contact where it co-localized with E-cadherin (arrowhead). In contrast, cells
negative for E-cadherin expression (small arrow) displayed reduced levels of only diffuse PTEN-ser380 immunofluorescence. is recruited to regions of cell-cell contacts where it may be stabilized by interactions with E-cadherin/β-catenin complexes. PTEN phosphorylation at serine residues has been associated with an increase in PTEN protein stability (48, 49) . Additional studies will be required to determine the mechanism(s) by which PTEN mRNA and protein are up regulated by E-cadherin, as well as the role of PTEN phosphorylation in the model of lrECM-mediated morphogenesis. 
DISCUSSION
